Effective anti-Alzheimer Aβ therapy involves depletion of specific Aβ oligomer subtypes.
Knight EM, Kim SH, Kottwitz JC, Hatami A, Albay R, Suzuki A, Lublin A, Alberini CM, Klein WL, Szabo P, Relkin NR, Ehrlich M, Glabe CG, Gandy S, Steele JW.
Knight EM, et al. Among authors: kim sh.
Neurol Neuroimmunol Neuroinflamm. 2016 May 10;3(3):e237. doi: 10.1212/NXI.0000000000000237. eCollection 2016 Jun.
Neurol Neuroimmunol Neuroinflamm. 2016.
PMID: 27218118
Free PMC article.